Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000938
Chunk: 42

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 42
---
)(1)(i) to (viii) under the Securities Act (a “”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3) under the Securities Act. The Company has exercised
reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.

5. COVENANTS.

(a) . The Company agrees that it shall, within the time required under the Exchange Act, file
with the SEC a report on Form 6-K relating to the transactions contemplated by, and describing the material terms and conditions of, this
Agreement and the Registration Rights Agreement (the “”). The Company shall also file with the SEC, within
forty-five (45) calendar days from the Execution Date, a new registration statement on Form F-1 (the “”)
covering only the resale of up to [35,000,000] Purchase Shares and, if applicable, up to 875,000 Commitment Shares (in each case, assuming
the issuance and sale of such shares at the Floor Price per Depositary Share), in accordance with the terms of the Registration Rights
Agreement between the Company and the Investor, dated as of the Execution Date (the “”).
The Company shall permit the Investor to review and comment upon the substantially final pre-filing draft version of the Current Report
at least two (2) Business Days prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The
Investor shall use its reasonable best efforts to comment upon the Current Report within one (1) Business Day from the date the Investor
receives the substantially final version thereof from the Company. The Investor shall cooperate with the Company as reasonably requested
by the Company in connection with the preparation and filing of the Current Report and the Registration Statement with the SEC.

(b) . The Company shall take all such action, if any, as is reasonably necessary in order to obtain an exemption for or to register
or qualify (i) the issuance of the Commitment Shares, if applicable, and the sale of the Purchase Shares to the Investor under this Agreement
and (ii) any subsequent resale of any Commitment Shares and all Purchase Shares by the Investor, in each case, under applicable securities
or “Blue Sky” laws of the states of the United States in such states as is reasonably requested by the Investor from time
to time, and shall provide evidence of any such action so taken to the Investor; provided, however